CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
142 hedge funds and large institutions have $907M invested in Cymabay Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
8% more funds holding
Funds holding: 131 → 142 (+11)
Holders
142
Holding in Top 10
5
Calls
$1.62M
Puts
$852K
Top Buyers
| 1 | +$24.9M | |
| 2 | +$24.1M | |
| 3 | +$23.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.3M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$15.3M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$10.6M | |
| 3 | -$8.11M | |
| 4 |
NC
Nexthera Capital
New York
|
-$6.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.64M |